National Bank of Canada FI Has $32 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

National Bank of Canada FI lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 9.9% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 101,585 shares of the company’s stock after purchasing an additional 9,163 shares during the period. National Bank of Canada FI’s holdings in HCA Healthcare were worth $32,001,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also bought and sold shares of HCA. TD Asset Management Inc raised its stake in HCA Healthcare by 2.7% during the second quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock worth $238,110,000 after buying an additional 19,812 shares during the last quarter. Cooke & Bieler LP lifted its stake in shares of HCA Healthcare by 9.8% in the second quarter. Cooke & Bieler LP now owns 215,748 shares of the company’s stock valued at $69,316,000 after buying an additional 19,217 shares in the last quarter. Markel Group Inc. lifted its holdings in shares of HCA Healthcare by 63.8% in the second quarter. Markel Group Inc. now owns 35,105 shares of the company’s stock valued at $11,279,000 after purchasing an additional 13,673 shares in the last quarter. Simon Quick Advisors LLC grew its holdings in HCA Healthcare by 8.4% during the second quarter. Simon Quick Advisors LLC now owns 672 shares of the company’s stock worth $216,000 after buying an additional 52 shares in the last quarter. Finally, Weaver Capital Management LLC lifted its stake in HCA Healthcare by 3.9% during the 2nd quarter. Weaver Capital Management LLC now owns 2,265 shares of the company’s stock valued at $728,000 after acquiring an additional 85 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. UBS Group raised their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. Morgan Stanley began coverage on HCA Healthcare in a report on Tuesday. They issued an “equal weight” rating and a $427.00 target price for the company. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Deutsche Bank Aktiengesellschaft lifted their target price on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research note on Friday, June 28th. Finally, Royal Bank of Canada lifted their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Five analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $359.89.

Get Our Latest Stock Analysis on HCA

HCA Healthcare Stock Down 2.5 %

HCA opened at $387.89 on Friday. The firm has a market capitalization of $101.59 billion, a P/E ratio of 19.34, a price-to-earnings-growth ratio of 1.52 and a beta of 1.68. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $403.05. The company has a fifty day moving average price of $355.43 and a 200-day moving average price of $335.92. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. During the same quarter in the previous year, the firm earned $4.29 earnings per share. HCA Healthcare’s revenue was up 10.3% on a year-over-year basis. Equities research analysts expect that HCA Healthcare, Inc. will post 22.5 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s payout ratio is currently 13.16%.

Insider Buying and Selling

In related news, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the transaction, the senior vice president now owns 9,454 shares in the company, valued at approximately $3,436,623.54. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the sale, the senior vice president now owns 9,454 shares of the company’s stock, valued at $3,436,623.54. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the sale, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The disclosure for this sale can be found here. Insiders sold 8,844 shares of company stock worth $3,185,932 in the last quarter. 1.60% of the stock is owned by insiders.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.